{
  "retracted": false,
  "timestamp": 1591833600000,
  "updates": [
    {
      "timestamp": 1591872039324,
      "identifier": {
        "doi": "10.1177/1078155220936492"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1177/1078155220915772"
  },
  "journal": "Journal of Oncology Pharmacy Practice",
  "publisher": "SAGE Publications",
  "title": "Corrigendum to Trends in use of primary prophylactic colony stimulating factors and neutropenia-related hospitalization in commercially insured patients receiving myelosuppressive chemotherapy in the United States: 2005â€“2017"
}
